div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documentdocument7-detry-et-al-atg-or-monoclonal-cd-3-antibodies-okt-3-were-used-inhtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: Document7 - uliegebe · Detry et al ATG or monoclonal CD-3 antibodies OKT 3 were used in steroid-resistant rejections Case reports Case l: A 59-yr-old man developed idiopathic loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsinreader034viewer20220502115f5d7bb0823c42629d43f890html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documentdocument7-detry-et-al-atg-or-monoclonal-cd-3-antibodies-okt-3-were-used-inhtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: Document7 - uliegebe · Detry et al ATG or monoclonal CD-3 antibodies OKT 3 were used in steroid-resistant rejections Case reports Case l: A 59-yr-old man developed idiopathic loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsinreader034viewer20220502115f5d7bb0823c42629d43f890html5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=documentdocument7-detry-et-al-atg-or-monoclonal-cd-3-antibodies-okt-3-were-used-inhtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: Document7 - uliegebe · Detry et al ATG or monoclonal CD-3 antibodies OKT 3 were used in steroid-resistant rejections Case reports Case l: A 59-yr-old man developed idiopathic loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII=...